Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Imipramine versus placebo for multiple functional somatic syndromes (STreSS-3): a double-blind, randomised study

Abstract

Background Functional somatic syndromes, including chronic fatigue syndrome or irritable bowel syndrome, often co-exist. Treatment guidelines supported by high quality evidence exist for most functional somatic syndromes, but are lacking for multiple comorbid functional somatic syndromes. We aimed to assess the effect of the tricyclic antidepressant, imipramine, in patients with multiple functional somatic syndromes defined by the criteria for multiorgan bodily distress syndrome, a unifying diagnosis that encompasses most functional somatic syndromes and somatoform disorders. Methods In this single-centre, double-blind, randomised trial done in a Danish university hospital setting, participants were patients consecutively referred (age 20-50 years) fulfilling criteria for multiorgan bodily distress syndrome with no concurrent comorbid depression or anxiety disorder. Participants were randomly assigned (1:1) to receive either 10 weeks of low-dose imipramine or placebo (oral daily doses of 25-75 mg). The hospital pharmacy handled randomisation (computer-generated) and masking, providing sequentially numbered packs of study drug that were given serially to the participants. All others involved were masked to allocation. Primary outcome was patient-rated overall health improvement on a 5-point clinical global improvement scale. Improvement was defined as patients responding "better" or "much better" as opposed to "unchanged" and "worse" or "much worse" when rating their overall h…

Overview

Integrity signals

Registry

Crossref · 10.1016/s2215-0366(17)30126-8

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 30 references

Cited by

See all 52

Metadata

Authors
Agger, J. L., Schröder, A., Gormsen, L. K., Jensen, J. S., Jensen, T. S., & Fink, P. K.
Affiliations
Aarhus University Hospital (DK)
Corresponding author
Agger, Johanne L
Venue
The Lancet Psychiatry
Publisher
Elsevier BV
Published
2017-05
Volume
4
Issue
5
Pages
378-388
ISSN
2215-0366 (ISSN-L)
OpenAlex
W2607259994
Cited by
52
References
30
Citations by year
2026: 2 · 2025: 9 · 2024: 6 · 2023: 3 · 2022: 2 · 2021: 4 · 2020: 4 · 2019: 7 · 2018: 9 · 2017: 6
FWCI
5.84
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Funders
Danish Foundation TrygFonden
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
tricyclic antidepressants, functional somatic syndromes, somatoform disorders, chronic fatigue syndrome, irritable bowel syndrome, comorbidities, Clinical Global Improvement, health-related quality of life, somatic symptoms, adverse events, premature treatment termination, young adults, stress
MeSH terms
Adult, Antidepressive Agents, Tricyclic, Denmark, Double-Blind Method, Female, Humans, Imipramine, Male, Middle Aged, Somatoform Disorders, Linear Models, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Imipramine versus placebo for multiple functional somatic syndromes (STreSS-3): a double-blind, randomised study. https://app.cochat.ai/papers/10.1016/s2215-0366(17)30126-8
The paper
Agger, J. L., Schröder, A., Gormsen, L. K., Jensen, J. S., Jensen, T. S., & Fink, P. K. (2017). Imipramine versus placebo for multiple functional somatic syndromes (STreSS-3): a double-blind, randomised study. The Lancet Psychiatry. https://doi.org/10.1016/s2215-0366(17)30126-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.